Human succinic semialdehyde dehydrogenase deficiency, an autosomal recessive disorder of γ-aminobutyric acid (GABA) catabolism, was modeled by a murine model sharing the phenotype of ataxia and seizures. Magnetic resonance imaging (MRI) with volumetry was obtained on 7 patients versus controls, and MRI with stereology was derived in 3 murine genotypes: null, wild-type, and heterozygous mutants. All patients had T1 hypointensity and T2 hyperintensity in globus pallidus, and 5 also had similar changes in subthalamic and cerebellar dentate nuclei. There was a trend for patients to have a smaller cerebellar vermis. Homozygous null mice had significantly lower total brain and cerebellar volumes than wild-types and heterozygotes. Stereology confirmed cerebellar atrophy and was otherwise normal in multiple regions. Cerebellar volume loss is present in the murine disorder with a trend for cerebellar atrophy in patients. Reduced cerebellar volume can reflect neurodegeneration and may be related to the clinical manifestations.
Chambliss KL , Caudle DL, Hinson DD, et al. Molecular cloning of the mature NAD(+)-dependent succinic semialdehyde dehydrogenase from rat and human. cDNA isolation, evolutionary homology, and tissue expression. J Biol Chem.1995;270: 461-467.
2.
Gibson KM, Aramaki S., Sweetman L., et al. Stable isotope dilution analysis of 4-hydroxybutyric acid: an accurate method for quantification in physiological fluids and the prenatal diagnosis of 4-hydroxybutyric aciduria. Biomed Environ Mass Spectrom. 1990;19:89-93.
3.
Pearl PL, Gibson KM, Acosta MT, et al. Clinical spectrum of succinic semialdehyde dehydrogenase deficiency . Neurology. 2003;60:1413-1417.
4.
Knerr I., Gibson KM, Jakobs C., Pearl PLNeuropsychiatric morbidity in adolescent and adult succinic semialdehyde dehydrogenase deficiency patients. CNS Spectr. 2008;13:598-605.
5.
Pearl PL, Acosta MT, Wallis DD, et al. Dyskinetic features of succinate semialdehyde dehydrogenase deficiency, a GABA degradative defect. In: Fernandez-Alvarez E, Arzimanoglu A, Tolosa E, eds. Paediatric Movement Disorders: Progress in Understanding. Montrouge, France: John Libbey Eurotext; 2005:203-212.
6.
Al-Essa MA , Bakheet SM, Patay ZJ, Powe JE, Ozand PTClinical, fluorine-18 labeled 2-fluoro-2-deoxyglucose positron emission tomography (FDG PET), MRI of the brain and biochemical observations in a patient with 4-hydroxybutyric aciduria; a progressive neurometabolic disease. Brain Dev . 2000;22: 127-131.
7.
Novotny EJ, Jr, Fulbright RK, Pearl PL, Gibson KM, Rothman DLMagnetic resonance spectroscopy of neurotransmitters in human brain. Ann Neurol . 2003;54:S25-S31.
8.
Ethofer T., Seeger U., Klose U., et al. Proton MR spectroscopy in succinic semialdehyde dehydrogenase deficiency. Neurology. 2004;62:1016-1018.
9.
Hogema BM, Gupta M., Senephansiri H., et al. Pharmacologic rescue of lethal seizures in mice deficient in succinate semialdehyde dehydrogenase. Nat Genet. 2001;29:212-216.
10.
Gupta M., Polinsky M., Senephansiri H., et al. Seizure evolution and amino acid imbalances in murine succinate semialdehyde dehydrogenase (SSADH) deficiency. Neurobiol Dis . 2004;16: 556-562.
11.
Bai Y., Markham K., Chen F., et al. The in vivo brain interactome of the amyloid precursor protein . Mol Cell Proteomics. 2008;7: 15-34.
12.
Gundersen HJ , Jensen EBThe efficiency of systematic sampling in stereology and its prediction. J Microsc. 1987; 147:229-263.
13.
Subbiah P., Mouton P., Fedor H., McArthur JC, Glass JDStereological analysis of cerebral atrophy in human immunodeficiency virus-associated dementia. J Neuropathol Exp Neurol. 1996;55: 1032-1037.
14.
Mouton PR, Price DL, Walker LCEmpirical assessment of synapse numbers in primate neocortex. J Neurosci Methods. 1997;75:119-126.
15.
Mouton PR, Long JM, Lei DL, et al. Age and gender effects on microglia and astrocyte numbers in brains of mice. Brain Res. 2002;956:30-35.
16.
Paxinos G., Franklin KBJ. In: The Mouse Brain in Stereotaxic Coordinates. 2nd ed. New York, NY: Academic Press ; 2003.
17.
Press GA, Murakami JW, Courchesne E., Grafe M., Hesselink JRThe cerebellum: 3. Anatomic-MR correlation in the coronal plane. AJR Am J Roentgenol. 1990;154:593-602.
18.
Lee SK, Mori S., Kim DJ, et al. Diffusion tensor MRI and fiber tractography of cerebellar atrophy in phenytoin users. Epilepsia. 2003;44:1536-1540.
19.
Rosenbaum T. , Engelbrecht V., Krolls W., van Dorsten FA, Hoehn-Berlage M., Lenard HGMRI abnormalities in neurofibromatosis type 1 (NF1): a study of men and mice. Brain Dev. 1999; 21:268-273.
20.
Blasi P., Palmerio F., Aiello A., Rocchi M., Malaspina P., Novelletto A.SSADH variation in primates: intra- and interspecific data on a gene with a potential role in human cognitive functions. J Mol Evol . 2006;63:54-68.
21.
Steinlin M.Cerebellar disorders in childhood: cognitive problems. Cerebellum. 2008;7:607-610.
22.
Timmann D., Daum I.Cerebellar contributions to cognitive functions: a progress report after two decades of research. Cerebellum. 2007;6:159-162.
23.
Blatt GJGABAergic cerebellar system in autism: a neuropathological and developmental perspective. Int Rev Neurobiol. 2005; 71:167-178.
24.
Fatemi SH, Reutiman TJ, Folsom TD, Thuras PDGABA(A) receptor downregulation in brains of subjects with autism . J Autism Dev Disord. 2009;39:223-230.
25.
Fatemi SH, Folsom TD, Reutiman TJ, Thuras PDExpression of GABA(B) receptors is altered in brains of subjects with autism . Cerebellum. 2009;8:64-69.
26.
Malaspina P. , Picklo MJ, Jakobs C., Snead OC, Gibson KMComparative genomics of aldehyde dehydrogenase 5a1 (succinate semialdehyde dehydrogenase) and accumulation of gamma-hydroxybutyrate associated with its deficiency. Hum Genomics. 2009;3:106-120.
